xAnts

Altimmune Explores Obesity Drug Pemvidutide for Alcohol Use Disorder Treatment

Reuters

Altimmune announces plans to investigate its lead obesity treatment, pemvidutide, for potential use in treating alcohol use disorder and associated liver disease, offering new hope for those struggling with addiction and related health issues. This i ...Read more